CTKB
Cytek Biosciences, Inc.
Medical Devices · Healthcare · United States
6.30
close · 2026-10-29
value
31
cheaper than peers31
quality
44
stronger fundamentals44
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 2.54× | 54 |
| price to sales | 2.98× | 48 |
| forward P/E | 90.00× | 13 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 8.2% | 81 |
| return on equity | -23.0% | 44 |
| revenue growth | 5.6% | 41 |
| operating margin | -29.5% | 30 |
4 of 4 measures available
Facts
| market cap | $819M |
| free cash flow | $9.3M |
| employees | 682 |
| first trade | 2021-07-23 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-17 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.52 | -0.05 | -0.09 | 0.02 |
| free cash flow | -$8.9M | $21.6M | $454,000 | -$22.1M |
| net income | -$66.5M | -$6.0M | -$12.1M | $2.6M |
| revenue | $201.5M | $200.5M | $193.0M | $164.0M |